Catalyst Wire Dossier Catalyst Wire Dossier

JTE-051

· Akros Pharma Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JTE-051, covering 2021-06-14 to 2021-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]

See pricing